GlaxoSmithKline | GSK - Cost Of Sales



GlaxoSmithKline reported GBP2.16B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AbbVie USD 4.35B 344M Jun/2025
Alcon AG USD 1.21B 118M Jun/2025
Almirall EUR 195.09M 100.89M Jun/2025
Amgen USD 3.01B 406M Jun/2025
argenx SE USD 110.75M 29.94M Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Biogen USD 605M 24.3M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Galapagos EUR 4.71M 9.02M Jun/2025
Genmab DKK 57M 15M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Glaxosmithkline GBP 2.16B 363M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Lonza CHF 2.47B 532M Dec/2024
Merck EUR 2.23B 93M Jun/2025
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Novo Nordisk 12.85B 44M Jun/2025
Orion EUR 168.1M 15.3M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Philips EUR 2.33B 79M Jun/2025
Recordati EUR 220.03M 1.16M Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
Smith & Nephew USD 870M 41M Jun/2025
UCB EUR 901M 50M Dec/2024